Pet cannabinoids brand expands into EuropeFebruary 21, 2023Portland, Maine-based pet CBD+CBDA company, ElleVet Sciences, opens new headquarters in Haarlem, the Netherlands.
SPONSORED CONTENTAre Your Patients Fully Protected?Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection. + Learn More
VPN Plus+ ExclusiveCBD or CBD and THC combined?May 29, 2020While cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are both phytocannabinoids derived from cannabis plants, differences in their chemical structures allow each to interact with unique receptors, resulting in distinct molecular targets and physiological effects. Namely, THC shows high affinity toward CB1 receptors, which are present in central and peripheral neurons, resulting in the euphoric effect commonly attributed to cannabis intoxication. In contrast, CBD does not bind CB1 at relevant concentrations and is nonintoxicating. Instead, CBD interacts, to various degrees, with other receptors (agonism at TRPV1 and 5-HT1A, antagonism at TNFα, GPR55, and GPR18), which may be relevant for its suggested therapeutic effects. Practical considerations Recently, CBD- and THC-containing products for people and pets have become more widely available, especially in jurisdictions that have passed legislation allowing the sale of such items intended for human use. Evolving regulatory frameworks and social perceptions have also renewed interest in the potential therapeutic properties of cannabinoids for animals. Importantly, there are no authorized veterinary drugs containing cannabinoids in the U.S., and any state laws permitting the use of medical cannabis do not apply to use in animals. Increasingly, the veterinary profession is being asked to weigh in on the potential roles of CBD and …
Penn Vet to study hemp-based canine supplementMay 28, 2019A trial at the University of Pennsylvania School of Veterinary Medicine (Penn Vet) will be looking at the effectiveness of a hemp-based supplement to relieve symptoms of canine joint immobility. Approximately 60 dogs who are suffering from inflammation secondary to osteoarthritis will be split into three groups. One group will receive Mobility, which was developed by Dixie Brands' subsidiary Therabis. The second group will receive CBD, and the last group will receive a placebo. The dogs will then be studied to see which group achieves a better outcome. "We are honored to have a Therabis product selected by the world-renowned experts at Penn Vet for their first major study of the effects of natural hemp oil to reduce joint pain in dogs," says Therabis cofounder, Stephen M. Katz, DVM. "Our experience in my clinic has shown cannabidiol (CBD) is an effective treatment in reducing inflammatory response. We have a passion for improving dogs' quality of life, and we look forward to learning all we can about therapeutic methods to achieve this." Physical tests will be used to measure the effectiveness of the products, mostly focusing on the front leg joints. Results are expected in approximately 12 months.
CBD and hemp product claims spike by 300 percent, says TrupanionApril 11, 2019Pet insurance claims for cannabidiol (CBD) and hemp products increased by 300 percent between 2017 and 2018. This is according to Trupanion, which says it has seen a large increase in submitted claims relating to CBD products over the past six years. The insurance company found more than 20 percent of Americans were living in states where recreational marijuana use was legal by 2017. This is up from five percent before California, Massachusetts, and Nevada were added to the list of states where it's legal. Based on Trupanion's data, the U.S. states with the most claims for CBD are: 1) Washington 2) New Jersey 3) Florida 4) New York There is an abundance of anecdotal evidence supporting the benefits of CBD and hemp products to pets, but little formal research. Tetrahydrocannabinol (THC) is toxic to pets, causing balance problems, irregular heartbeat, incontinence, or worse. Inhalation by second-hand smoke can be dangerous too, as well as edible forms of THC. The top conditions pet owners use CBD or hemp for their pets are seizures, musculoskeletal issues, such as arthritis and hip dysplasia, cancer, and behavioral issues, like anxiety.
Martha Stewart to enter animal CBD market with new partnershipFebruary 28, 2019A good thing could be in the works for pet well-being thanks to a collaboration between lifestyle guru and animal lover Martha Stewart and Canopy Growth Corp. The Canadian cannabis and hemp company announced today that Stewart has joined Canopy in an advisory role to assist with developing and positioning a broad new line of product offerings. "I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living," Stewart said. "I'm especially looking forward to our first collaboration together, which will offer sensible products for people's beloved pets." Stewart is a vocal advocate for animals, championing the health and wellness of pets and farm animals alike. According to Canopy, several clinical trials are underway to explore the effectiveness of CBD and other cannabinoids as they relate to improving the lives of both humans and animals. The company says it will be guided by Stewart's knowledge of consumer products and merchandising. "As soon as you hear the name Martha, you know exactly who we're talking about," said Canopy Growth chair and co-CEO, Bruce Linton. "Martha is one of a kind and I am …
